Corvus Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.
Corvus Pharmaceuticals stock last closed at $2.35, up 1.73% from the previous day, and has increased 212.08% in one year. It has overperformed other stocks in the Biotechnology industry by 2.36 percentage points. Corvus Pharmaceuticals stock is currently +287.15% from its 52-week low of $0.61, and -43.91% from its 52-week high of $4.19.
As of Feb 23, 2024, there are 49.04M CRVS shares outstanding. The market capitalization of CRVS is $115.24M. In the last 24 hours, 105,488 CRVS shares were traded.
How to Buy Corvus Pharmaceuticals Stock
Not sure how to invest in Corvus Pharmaceuticals stock? Here's how.
Decide where to buy Corvus Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Corvus Pharmaceuticals stock.
Fund your brokerage account: Pick your method of payment and add your info.
Research Corvus Pharmaceuticals stock: The Corvus Pharmaceuticals ticker symbol is CRVS. Is Corvus Pharmaceuticals stock a good investment? Should you buy shares of CRVS? How do CRVS's underlying business fundamentals look? Do top analysts think Corvus Pharmaceuticals is a good buy? Why has CRVS's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if CRVS is a good stock to buy).
Execute your CRVS purchase: Decide if you will purchase CRVS shares at the current market price or use a limit order to purchase CRVS stock at a particular price.
Keep tabs on your CRVS investment: Create a watchlist to keep tabs on your investment in Corvus Pharmaceuticals stock.
Step 1: Decide where to buy Corvus Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy CRVS shares.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Energy, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal details so you are able to invest in CRVS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Corvus Pharmaceuticals stock
After you have chosen the best place to buy Corvus Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.
Corvus Pharmaceuticals stock at a glance
Fore. Rev. Growth
Fore. Earn. Growth
Mar 26, 2024
Corvus Pharmaceuticals Fundamentals
WallStreetZen was built to help part-time investors do better fundamental analysis in minutes instead of hours.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.